Beta Bionics, Inc. Common Stock

BBNXNASDAQ • USD
ThemeMedical Devices & HealthTech›Wearable Medical Devices
17.28 USD
↗ 0.71 (4.26%)🟢LIVE (AS OF 01:14 PM EDT)
🟢Market: OPEN

Beta Bionics, Inc. Common Stock (BBNX) trades at $17.28 per share. Technicals currently rate "Sell" while our fundamental analysis reads "Neutral". This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. On valuation, BBNX trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Sep 11, 2026.

Open?$15.52
High?$17.58
Low?$13.00
Prev. Close?$16.57
Volume?1.2M
Avg. Volume?1.2M
VWAP?$16.64
Rel. Volume?1.05x
Bid / Ask
Bid?$14.87 × 100
Ask?$17.46 × 100
Spread?$2.59
Midpoint?$16.17
Valuation & Ratios
Market Cap?745.5M
Shares Out?45.0M
Float?28.3M
Float %?63.5%
P/E Ratio?N/A
P/B Ratio?2.91
EPS?-$1.62
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.
Themes
Medical Devices & HealthTech›Wearable Medical DevicesDigital Health & Telemedicine›Remote Patient Monitoring
Employees
423
Market Cap
745.5M
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Website
www.betabionics.com
Listed
2025-01-30
Address
11 HUGHES
IRVINE, CA 92618
Phone: 949-427-7785
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
85
Short Sent.?
6
Piotroski F-Score?0/9Weak
Altman Z-Score?10.74Safe
Confidence?45%Low
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?33.21%Squeeze Risk
Short Interest?9.4M
Days to Cover?9.0
Free Float28.3M
Avg Daily Volume1.0M
Settlement Date2026-08-31
Financial Health
Current Ratio?8.88Strong
Quick Ratio?7.96Strong
Cash Ratio?1.70Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A▾
P/B?
Peers
100
S&P
57
2.91CHEAP▾
P/S?
Peers
100
S&P
20
6.26FAIR▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-8.7CHEAP▾
EV/Sales?
Peers
100
S&P
29
5.89FAIR▾
Returns & Efficiency
ROE?
S&P
6
-28.5%WEAK▾
ROA?
S&P
3
-25.0%WEAK▾
Cash Flow & Enterprise
FCF?$-61411000
Enterprise Value?$701.2M
Fundamentals ratios updated end of day
MarketsMoversWatchlist